title: Translational medicine: Cancer lessons from mice to humans.
authors.forename: David
authors.initials: D
authors.lastname: Tuveson
authors.forename: Douglas
authors.initials: D
authors.lastname: Hanahan
mesh_terms: D000818:Animals; D017326:Clinical Trials, Phase III as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D000068338:Everolimus; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D011758:Pyrroles / Q000494:pharmacology* / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000077210:Sunitinib; D015996:Survival Rate; D057170:Translational Research, Biomedical
chemical_list: D007211:Indoles; D011758:Pyrroles; D000068338:Everolimus; D000077210:Sunitinib; D020123:Sirolimus